Colony‐stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia

BACKGROUND: Acute myelogenous leukemia (AML) is a fatal bone marrow cancer. Colony‐stimulating factors (CSFs) are frequently administered during and after chemotherapy to reduce complications. However, their safety with regard to disease‐related outcomes and survival in AML is unclear. Therefore, we...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cochrane Database Syst Rev
Asıl Yazarlar: Gurion, Ronit, Belnik‐Plitman, Yulia, Gafter‐Gvili, Anat, Paul, Mical, Vidal, Liat, Ben‐Bassat, Isaac, Shpilberg, Ofer, Raanani, Pia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley & Sons, Ltd 2012
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7390444/
https://ncbi.nlm.nih.gov/pubmed/22696376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD008238.pub3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller